Decline depth
-20.7%
From rolling 252-day high of $15.42, 86d ago.
Past the 20% Watch threshold.
Watch
AMRX
Amneal Pharmaceuticals, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic · mid-cap ($3.9B)
-20.7%
from rolling 252-day high of $15.42 set 2026-02-17 · 86d ago
Current
$12.23
Decline depth
-20.7%
Decline σ
5.1σ
TFC
3/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Structural break signals
AMRX qualifies for the Watch on decline depth.
Time-frame continuity
3/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Past the 3/5 Watch threshold.
Decline sigma
5.1σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (2.45% per day).
Past the ≥4σ Watch threshold.
The structural read
What price action says about AMRX.
AMRX qualifies for the Watch on decline depth — down -20.7% from its rolling 252-day high.
Cross-confirmation: also showing 3/5 bearish time frames.
Cross-confirmation: decline sigma also reads 5.1σ over 20 bars.
Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 2D (red), weekly 2D (red), monthly 1 (red).
Earnings on file: 2026-05-01. Tiering is unaffected by earnings dates — listings reflect price structure only.
52-week range
52W low $7.02
62.0% of range
52W high $15.42
Sector context · Healthcare
182 other Healthcare tickers are on Broken Stocks.
93
Red List
43
Amber
46
Watch
-35.8%
Median decline
Worst in sector: OPRX (-76.7%). Least-bad: ANIP (-20.0%). See all Healthcare listings →
Related — same sector
Closest decliners to AMRX
Amber List
PHG
Koninklijke Philips N.V. NY Reg
Watch
FDMT
4D Molecular Therapeutics, Inc.
Watch
PGNY
Progyny, Inc.
Watch
IMNM
Immunome, Inc.
Watch Recovering
OMCL
Omnicell, Inc.
Watch Recovering
ANGO
AngioDynamics, Inc.
Questions about AMRX
What people ask.
Why is AMRX on Broken Stocks?
AMRX qualifies for the Watch on decline depth. It is down -20.7% from its rolling 252-day high of $15.42, set on 2026-02-17 — 86d ago.
Is AMRX a falling knife?
No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. AMRX is down -20.7% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.
Is AMRX a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is AMRX trading inside its 52-week range?
At $12.23, AMRX sits 62.0% of the way from its 52-week low ($7.02) to its 52-week high ($15.42). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has AMRX been declining?
The current 20.7% decline accrued over 86d, which annualizes to roughly -87.9% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does AMRX compare to its sector?
There are 182 other Healthcare tickers on Broken Stocks: 93 Red, 43 Amber, 46 Watch, with 55 showing recovering structural signals. Median sector decline is -35.8% — AMRX's decline is shallower than the sector median.
Does AMRX's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-01) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.